| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Scientific Officer | Chief Scientific Officer
1 company
Krill Steven L. is an EVP &Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $750 based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2017 | EGRX Eagle Pharmaceuticals, Inc. | EVP &Chief Scientific Officer | Sale+OE | 14,125 | $81.07 | $1,145,130.19 | -100% | |
| Dec 23, 2016 | EGRX Eagle Pharmaceuticals, Inc. | EVP &Chief Scientific Officer | Sale+OE | 50,505 | $76.40 | $3,858,621.81 | -100% | |
| Dec 13, 2016 | EGRX Eagle Pharmaceuticals, Inc. | EVP &Chief Scientific Officer | Sale+OE | 10,000 | $73.62 | $736,163.00 | -100% | |
| Nov 30, 2016 | EGRX Eagle Pharmaceuticals, Inc. | EVP &Chief Scientific Officer | Sale+OE | 5,987 | $80.00 | $478,960.00 | -100% | |
| Jun 16, 2015 | EGRX Eagle Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 9,980 | $81.60 | $814,368.00 | -100% |